Community Relations Special Event Partnership
Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer.
Immunotherapy—empowering our own immune system to kill tumors—has revolutionized the treatment of cancer. This evolving form of therapy is designed to prime the body’s own immune system to fight the disease head-on. Doctors report promising results, including tough-to-treat tumors melting away. For some patients, such as those with melanoma and lung cancer, immunotherapy has increased survival rates from months to years.
However, the treatment doesn’t work for everyone, and even when it does work initially, it can lose effectiveness as time goes on. Why do some people respond to treatments and others do not? Which cancers respond best to immunotherapy?
Join us to hear from those on the leading edge of immunotherapy research:
- How does immunotherapy work?
- Why do some cancers turn “blind eye†to immunotherapy?
- What does the future hold for expanding the benefit of immunotherapy to more patients?
A Q&A session will follow the presentation and will give you an opportunity to personally connect with our scientists and have your questions answered.
Don’t miss this chance to connect with our scientists and have your questions answered!
Please submit questions in advance using the button above.
Event recording
Co-Director and Professor
Aging, Cancer and Immuno-oncology Program
NCI-Designated Cancer Center
Sanford Burnham Prebys
Postdoctoral Fellow, Bradley Lab
Aging, Cancer and Immuno-oncology Program
NCI-Designated Cancer Center
Sanford Burnham Prebys
Staff Scientist and Project Manager, Bradley Lab
Aging, Cancer and Immuno-oncology Program
NCI-Designated Cancer Center
Sanford Burnham Prebys